Clinical Trial Update: Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the effects of semaglutide on energy intake, appetite sensations, postprandial glucose, triglyceride metabolism, and gastric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Metabolism and Nutrition Disorder | Phase 1 | Status: COMPLETED